Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 26, 2021; 9(36): 11248-11254
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11248
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11248
Group | n | TIMI | |
Grades 0 to II | Grade III | ||
Experimental | 360 | 28 (7.8) | 332 (92.2) |
Control | 380 | 79 (20.8) | 301 (79.2) |
χ2 value | 12.422 | 12.422 | |
P value | 0.001 | 0.001 |
Group | n | LVEDD (mm) | LVEF (%) |
Experimental | 360 | 54.21 ± 5.38 | 50.83 ± 8.38 |
Control | 380 | 56.78 ± 4.90 | 47.56 ± 5.47 |
t value | 6.329 | 7.542 | |
P value | 0.034 | 0.027 |
Group | n | Malignant arrhythmia | Intractable myocardial ischemia | Congestive heart failure | Recurrent myocardial infarction | Death | Overall incidence |
Experimental | 360 | 3 | 3 | 4 | 5 | 1 | 16 (4.4) |
Control | 380 | 8 | 5 | 7 | 14 | 2 | 36 (9.5) |
χ2 value | 9.124 | ||||||
P value | 0.001 |
- Citation: Yu Y, Yang BP. Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention. World J Clin Cases 2021; 9(36): 11248-11254
- URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11248.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11248